![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 42, 32598-32602, October 20, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From
Received for publication, May 30, 2000, and in revised form, July 19, 2000
A new
To obtain insights into the functions of the N-linked
glycans, it is essential to purify and to clone the enzymes responsible for their biosynthesis. Six different
N-acetylglucosaminyltransferases (GnTs),1 I-VI, are known to
be mainly involved in the branch formation on the cores of
N-linked complex-type sugar chains. These enzymes are named
as shown in Fig. 1 (1). GnT VI activity
is defined as that catalyzing the transfer of GlcNAc to the Man This study reports the purification of GnT VI from hen oviduct, which
has been previously shown to have high activity (20). By successive
column chromatographies using Q-Sepharose FF,
Ni2+-chelating Sepharose FF, and UDP-hexanolamine-agarose
with a newly developed assay method (21) wherein pyridylaminated
agalactotetraantennary oligosaccharide ([(2,4),(2,6)]-PA) (see Fig.
2) was used as an acceptor substrate and the reaction product was
pyridylaminated agalactopentaantennary oligosaccharide
([(2,4),(2,4,6)]-PA) (see Fig. 2), this enzyme was purified
64,000-fold from a homogenate of hen oviduct. Using several acceptor
compounds, the purified enzyme was shown to have an absolute
requirement of GlcNAc Materials--
All materials were obtained from the following
suppliers: UDP-GlcNAc, UDP-hexanolamine-agarose (ligand concentration
of 2.4 µmol/ml), and GlcNAc from Sigma; Q-Sepharose FF and chelating Sepharose FF from Amersham Pharmacia Biotech (Uppsala, Sweden); Tris,
HEPES, MES, and MOPS from Nacalai Tesque (Kyoto, Japan); Triton X-100,
(p-amidinophenyl)methanesulfonyl fluoride hydrochloride, glycine, DTT, and metal chlorides from Wako (Osaka, Japan); [(2, 4),2]-PA from Takara Co. (Kyoto); and hen oviduct from Benchyo (Osaka).
Determination of GnT VI Activity--
GnT VI activity was
assayed as described previously (21) with minor modifications. The
standard incubation mixture contained the following components in a
total volume of 10 µl: 150 mM HEPES (pH 8.0), 10 mM UDP-GlcNAc, 100 mM GlcNAc, 30 mM
MnCl2, 0.5% Triton X-100, 2 mg/ml bovine serum albumin, 24 or 120 pmol of substrate ([(2,4),(2,6)]-PA), and 2 µl of enzyme
fraction. After incubation at 37 °C for 4 h, 40 µl of water
was added, and the enzyme reaction was stopped by boiling for 1 min.
After centrifugation at 13,000 rpm for 5 min, 10 µl of the
supernatant from the reaction mixture was applied to a TSK-Gel ODS-80TM
column (4.6 × 75 mm; Tosoh, Tokyo, Japan). Elution was performed
at 55 °C with 20 mM ammonium acetate (pH 4.0) at a flow
rate of 1.6 ml/min. Fluorescence was monitored with excitation and
emission wavelengths of 320 and 400 nm, respectively. The specific
activity of the enzyme is expressed as picomoles of product formed
per h/mg of protein. The protein concentration was determined
with a BCA kit (Pierce) or a Bio-Rad protein assay kit using bovine
serum albumin as the standard. The activities of GnTs III-V were
measured according to the method of Nishikawa et al.
(22).
Preparation of Oligosaccharides--
The structures of all
oligosaccharides used in this assay are shown in Fig.
2. [(2,4),(2,6)]-PA was prepared from
human Buffers Used in Purification of GnT VI--
The buffers used in
this study were as follows: Buffer A, 0.25 M sucrose, 20 µM (p-amidinophenyl)methanesulfonyl fluoride hydrochloride, and 10 mM Tris-HCl (pH 7.5); Buffer B, 20%
glycerol, 20 µM
(p-amidinophenyl)methanesulfonyl fluoride hydrochloride, 1%
Triton X-100, and 10 mM Tris-HCl (pH 7.5); Buffer C, 20%
glycerol, 0.1% Triton X-100, and 10 mM Tris-HCl (pH 8.4);
Buffer D, 20% glycerol, 0.4 M NaCl, 0.1% Triton X-100,
and 20 mM Tris-HCl (pH 8.0); Buffer E, 20% glycerol,
0.05% Triton X-100, 10 mM MnCl2, 1 mM DTT, and 20 mM MOPS (pH 7.4); Buffer F, 20%
glycerol, 0.05% Triton X-100, 1 mM DTT, 0.05 M
NaCl, and 20 mM MOPS (pH 7.4); and Buffer G, 20% glycerol,
0.05% Triton X-100, 20 mM MnCl2, 1 mM DTT, and 20 mM MOPS (pH 7.4). pH
measurements were performed at 4 °C.
Homogenization and Preparation of the Microsomal Fraction (Step
1)--
All purification steps were carried out at 4 °C. Frozen hen
oviduct (270 g) was homogenized in a Waring Blendor in Buffer A. After
centrifugation at 8000 rpm for 10 min, the supernatant was pooled, and
the pellet was subjected to two more extractions, after which all the
supernatants (1200 ml) were combined. Following centrifugation at
78,000 × g for 2 h, a microsomal fraction of ~13 g was obtained.
Solubilization of GnT VI (Step 2)--
The microsomal fraction
was suspended in 150 ml of Buffer B, gently stirred for 2 h, and
then centrifuged at 105,000 × g for 1 h. The
supernatant fraction was collected, and the residual pellet was
subjected to another extraction, followed by the same ultracentrifugation. The first and second Triton X-100 extracts were
combined and used for further enzyme purification.
Q-Sepharose FF Column Chromatography (Step 3)--
The Triton
X-100 extracts were applied to a column of Q-Sepharose FF (10 × 4 cm) that had been equilibrated with Buffer C. Fractions of 40 ml were
collected through this column chromatography. The column was washed
with Buffer C until the protein concentration was reduced to 1.0 mg/ml.
Elution was then carried out with a linear gradient established between
1000 ml of Buffer C and 1000 ml of 0.8 M NaCl/Buffer C. The
fractions containing GnT VI activity were combined.
Ni2+-chelating Sepharose FF Column Chromatography
(Step 4)--
The pool of fractions from Step 3 was applied directly
to a column of Ni2+-chelating Sepharose FF (2.5 × 10 cm) that had been equilibrated with Buffer D. Ni2+-chelating Sepharose FF resin was layered on the
chelating Sepharose FF resin without metal ions (2.5 × 5 cm) to
avoid any possible leakage of Ni2+. Fractions of 11 ml were
collected through this column chromatography. All of the GnT VI
activity was retained by the column. After washing the column with
Buffer D until the protein concentration was reduced to 0.2 mg/ml, GnT
VI activity was eluted with a linear gradient established between 300 ml of Buffer D and 300 ml of 0.1 M glycine/Buffer D. The
fractions containing GnT VI activity were combined, and the buffer in
this fraction was replaced by Buffer E by means of an Amicon Diaflow
Ultrafiltrater using a YM-30 membrane (Amicon, Inc., Beverly, MA).
UDP-hexanolamine-Agarose Affinity Column Chromatography (Step
5)--
After the above step, the column was siliconized with
Sigmacote (Sigma), and siliconized tubes (Assist, Tokyo) were used for fractionation. The UDP-hexanolamine-agarose column (1.5 × 15 cm) had been equilibrated with 0.05 M NaCl/Buffer E, and the
concentrated enzyme fraction from Step 4 was applied to the column,
followed by washing with 100 ml of Buffer E. GnT VI activity was eluted with Buffer F. At the loading and washing steps, fractions of 5 ml were
collected. At the elution step, fractions of 1.4 ml were collected, and
those containing GnT VI activity were pooled.
UDP-hexanolamine-Agarose Affinity Column Chromatography (Step
6)--
An equal volume of Buffer G was added to the pool of fractions
from Step 5, and this solution was rechromatographed by the same
procedure as described for Step 5. This purified GnT VI fraction was
used for the enzyme characterization.
Gel Electrophoresis--
SDS-polyacrylamide gel electrophoresis
was performed by the method of Laemmli (23) using 10% gels. Molecular
markers (Amersham Pharmacia Biotech, Little Chalfont, United Kingdom)
were used for size standards. Proteins on the gels were stained with a
silver staining kit (DAIICHI 2D silver stain II, Daiichi Pure
Chemicals, Tokyo).
Purification of GnT VI--
The activity of GnT VI was assayed
using the fluorescently labeled agalactotetraantennary sugar
chain as an acceptor substrate basically according to the original
method of Taguchi et al. (21). Since bovine serum albumin (2 mg/ml) was found to be effective in preserving enzyme activity at
37 °C, especially for the highly purified enzyme fraction (Steps 5 and 6), it was routinely included in the standard assay mixture.
Like other glycosyltransferases, GnT VI activity was found in the
microsomal fraction. At least 80% of the GnT VI activity was
associated with the microsomal fraction. GnT VI activity was successfully solubilized from the microsomal fraction by extraction with Triton X-100. Substantial amounts of proteins were separated from
GnT VI by Q-Sepharose FF and Ni2+-chelating Sepharose FF
chromatographies (Fig. 3, A and
B). After the
Ni2+-chelating Sepharose FF column chromatography (Step 4),
the enzyme was more stable than in Steps 2 and 3. As opposed to results
with GnTs III and IV (11, 13), no GnT VI activity was eluted after application to a Cu2+-chelating column. Following the above
two column chromatography steps, the GnT VI active fraction still
contained GnT III and pH Optimum--
GnT VI possessed activity over a relatively broad
pH range with an optimum at pH 7.75.
Effect of MnCl2 Concentration on GnT VI
Activity--
GnT VI activity was
Mn2+-dependent and was high around 5 mM. When the MnCl2 concentration was increased,
the activity gradually decreased.
Effect of Divalent Cations on GnT VI Activity--
The effects of
divalent cations on GnT VI activity were examined. The activity was
maximal with Mn2+. Co2+, Mg2+, and
Ni2+ could partially substitute for Mn2+,
whereas Ca2+, Zn2+, Fe2+, and
Cu2+ showed no significant effect (Table
II).
Acceptor Substrate Specificity--
The acceptor substrate
specificity of GnT VI was examined using complex-type sugar chains.
Purified GnT VI was revealed to select its substrate clearly (Table
III). It could transfer GlcNAc to
[(2,4),(2,6)]-PA and [2,(2, 6)]-PA (GnT V product), whereas no
activity was observed when [2,2]-PA or [(2,4),2]-PA (GnT IV product) was used as a substrate.
Six different GnTs (I-VI) are known to be mainly involved in
antenna formation on the cores of N-linked complex-type
sugar chains (Fig. 1). In addition, Raju and Stanley (24) recently identified two other distinct GnT activities designated GnTs VII and
VIII from Chinese hamster ovary mutant cells. GnT VI activity is
defined as that catalyzing the transfer of GlcNAc to the Man In this study, we have purified GnT VI from hen oviduct 64,000-fold
with a newly developed assay method (21) wherein [(2,4),(2,6)]-PA (Fig. 2) was used as an acceptor substrate, and the reaction product was [(2,4),(2,4,6)]-PA (Fig. 2). Cloning of this GnT VI gene is now
in progress based on the peptide sequences obtained from the purified
enzyme. The specificity of this purified GnT VI is summarized as
follows (see Table III). (a) no GnT III and IV activities
were observed, both of which can act on [2,2]-PA and produce
GlcNAc
Purification and Characterization of
UDP-GlcNAc: GlcNAc
1-6(GlcNAc
1-2)Man
1-R [GlcNAc to
Man]-
1, 4-N-acetylglucosaminyltransferase VI from
Hen Oviduct*
§¶,
,
,
,
RIKEN (Institute of Physical and Chemical
Research), Wako, Saitama 351-0198, Japan, the § Department
of Biochemistry, Osaka University Medical School, Suita, Osaka
565-0871, Japan, and the
Institute of Biological Chemistry,
Academia Sinica, Taipei 115, Taiwan
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1,4-N-acetylglucosaminyltransferase (GnT) responsible
for the formation of branched N-linked complex-type sugar
chains has been purified 64,000-fold in 16% yield from a homogenate of hen oviduct by column chromatography procedures using Q-Sepharose FF,
Ni2+-chelating Sepharose FF, and UDP-hexanolamine-agarose.
This enzyme catalyzes the transfer of GlcNAc from UDP-GlcNAc to
tetraantennary oligosaccharide and produces pentaantennary
oligosaccharide with the
1-4-linked GlcNAc residue on the
Man
1-6 arm. It requires a divalent cation such as Mn2+
and has an apparent molecular weight of 72,000 under nonreducing conditions. The enzyme does not act on biantennary oligosaccharide (GnT
I and II product), and
1,6-N-acetylglucosaminylation of the Man
1-6 arm (GnT V product) is essential for its activity. This
clearly distinguishes it from GnT IV, which is known to generate a
1-4-linked GlcNAc residue only on the Man
1-3 arm. Based on these findings, we conclude that this enzyme is
UDP-GlcNAc:GlcNAc
1-6(GlcNAc
1-2)Man
1-R [GlcNAc to
Man]-
1,4-N-acetylglucosaminyltransferase VI. This is
the only known enzyme that has not been previously purified among GnTs
responsible for antenna formation on the cores of N-linked complex-type sugar chains.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1-6
arm and forms GlcNAc
1-4Man
1-6 linkage. Examples of the most
highly branched N-linked complex-type glycan, which is a
pentaantennary glycan with a bisecting GlcNAc residue, were found in
hen ovomucoid (2, 3) and in the fish egg glycoprotein known as
hyosophorin (4). GnTs I-V have been purified, and the
corresponding genes have been cloned (5-19). Only GnT VI has not been
purified, and its gene structure remains unknown.

View larger version (11K):
[in a new window]
Fig. 1.
GlcNAc-transferases (GnTs I-VI) involved in
antenna formation on the cores of N-linked
complex-type sugar chains.
1-2(GlcNAc
1-6)Man
1-R substrate
sequence. The GnT VI enzyme is distinct from GnT IV, which generates a
1-4-linked GlcNAc residue only on the Man
1-3 arm (13).
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1-acid glycoprotein essentially as described
previously (21). [2,2]-PA for assay of GnTs III-V was prepared
essentially as described previously (22). [2,(2,6)]-PA
oligosaccharide was prepared from [2,2]-PA by reaction with
UDP-GlcNAc, catalyzed by GnT V derived from the culture medium of QG
cells (17). All of these structures were confirmed by methylation
analysis and mass spectrometry.

View larger version (29K):
[in a new window]
Fig. 2.
Structures and abbreviations for
pyridylaminated sugar chains used in this study. The
numbers in brackets show the positions of the two
-Man residues to which nonreducing terminal GlcNAc residues are
linked. The first set of parentheses indicate GlcNAc
residues linked to the
-Man residue (Man-4) that is linked to the
-Man residue by 1-3 linkage, and the second set of
parentheses indicate GlcNAc residues linked to the
-Man residue
(Man-4') that is linked to the
-Man residue by 1-6 linkage. For
example, [(2,4),(2,6)]-PA indicates the structure in which two GlcNAc
residues are linked to Man-4 by
1-2 and
1-4 linkages and two
GlcNAc residues are linked to Man-4' by
1-2 and
1-6
linkages.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1,4-galactosyltransferase activities.
Cation exchange, dye affinity, gel filtration, and lectin column
chromatographies did not prove to be effective for further purification
of the enzyme fraction after Step 4. The use of an affinity column
(Steps 5 and 6) (Fig. 3C) packed with an analog of the
common donor substrate for GnTs (UDP-hexanolamine) as a ligand was
effective. This affinity column has been proven to be very effective
for purification of GnTs and was first used for the purification of GnT
I by Oppenheimer and Hill (5). The activity of GnT III was not
bound to this column under the conditions described under
"Experimental Procedures." The majority of GnT VI activity was
bound to this affinity column and was eluted by the buffer lacking
MnCl2. Since the eluted fraction (after Step 5) still
contained several proteins as revealed by SDS-polyacrylamide gel
electrophoresis (data not shown), this fraction was rechromatographed
(Step 6) under the same conditions as described for Step 5. The
addition of DTT was crucial in preserving GnT VI activity after Steps 5 and 6, whereas it was without effect in Step 4. The enzyme fraction of
Step 6 showed a single broad band with a molecular weight of 72,000 on
SDS-polyacrylamide gel electrophoresis under nonreducing conditions
(Fig. 4) and of 60,000 under reducing
conditions (data not shown), suggesting that the enzyme was a
glycoprotein. This band was also correlated with GnT VI activity by
elution with UDP (5 mM) or NaCl (0.4 M) from a
UDP-hexanolamine-agarose column, suggesting that this band was GnT VI
(data not shown). No GnT III-V activities were detected in this
fraction when [2,2]-PA was used as an acceptor substrate. All
experiments for enzyme characterization described below were performed
using the chromatographic Step 6 material. Table
I summarizes the purification of GnT VI,
which was purified 64,000-fold in 16% yield.

View larger version (18K):
[in a new window]
Fig. 3.
Chromatographic elution patterns obtained in
the purification of GnT VI. A, Q-Sepharose FF column
chromatography (Step 3); B, Ni2+-chelating
Sepharose FF column chromatography (Step 4); C,
UDP-hexanolamine-agarose column chromatography (Step 5). Fractions
indicated by bars were pooled.

View larger version (32K):
[in a new window]
Fig. 4.
SDS-polyacrylamide gel electrophoresis of GnT
VI. A purified GnT VI fraction (after Step 6) was analyzed on a
10% SDS-polyacrylamide gel under nonreducing conditions and stained
with silver. The position of GnT VI is indicated by the
arrow. K indicates molecular weight in
thousands.
Purification of GnT VI from hen oviduct
Effects of metal ions on GnT VI activity
Substrate specificity of GnT VI
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1-6 arm
and forms a GlcNAc
1-4Man
1-6 linkage. Only GnT VI has not been
purified in the GnTs that act on
-Man residues. The substrate specificity of GnT VI has not been clearly determined, although it has
been suggested, by using hen oviduct microsomes as an enzyme source,
that GnT VI acts after assembly of GlcNAc
1-2Man
1-3-, GlcNAc
1-2Man
1-6-, and GlcNAc
1-6Man
1-6- antennae by the
action of GnTs I, II, and V, respectively (20). The tissue distribution of this enzyme seems to be highly restricted. So far, only avian oviduct (20) and fish ovary (25) have been shown to express this enzyme
activity. The transferrin synthesized by the human hepatocarcinoma cell
line HepG2 was reported to have a pentaantennary glycan chain (26),
which is the product of GnT VI activity.
1-4 linkages on the
-linked Man residue and the
Man
1-3 residue, respectively (11, 13). (b) GnT VI
activity was observed when [(2,4),(2,6)]-PA and [2,(2,6)]-PA were
used as acceptor substrates. (c) GnT VI activity was not
detected when [(2,4),2]-PA was used as a substrate. From these
observations, it is concluded that
1,6-N-acetylglucosaminylation to the Man
1-6 arm (GnT
V product) is essential for its activity. This defines GnT VI activity
as UDP-GlcNAc:GlcNAc
1-6(GlcNAc
1-2)Man
1-R [GlcNAc to
Man]-
1,4-N-acetylglucosaminyltransferase. This
characteristic clearly distinguishes this enzyme from GnT IV, which is
known to generate a
1-4-linked GlcNAc residue only on the
Man
1-3 arm (13). In addition, it should be pointed out that this
purified GnT VI does not have GnT VI' activity, which is defined as
that making GlcNAc
1-2(GlcNAc
1-4)Man
1-6 linkage without the
requirement of a GlcNAc
1-6Man
1-6 structure (27), since no
product was detected when [2,2]-PA was used as a substrate. In
conjunction with previous observations, the biosynthetic
pathways leading to a bisected pentaantennary glycan chain are depicted in Fig. 5.

View larger version (28K):
[in a new window]
Fig. 5.
Biosynthetic pathways leading to a bisected
pentaantennary N-glycan. Gn, GlcNAc;
M, Man.
The substrate specificity of purified GnT VI agrees with the results
reported by Brockhausen et al. (20) in a study using hen
oviduct microsomes as the enzyme source and
GlcNAc
1-6(GlcNAc
1-2)Man
1-6Man
1-(CH2)8COOCH3 as an acceptor substrate. Some differences from their results in terms
of optimal conditions for activity, e.g. the effect of Mn2+ concentration and the effects of divalent cations, are
to be noted. Differences are also noted for the optimal conditions of enzyme from hen oviduct microsomes (21) and this purified GnT VI using
the same substrate, [(2,4),(2,6)]-PA. Such discrepancies could be due
to the presence of another (or other) GnT VI(s) in hen oviduct microsomes.
| |
ACKNOWLEDGEMENT |
|---|
We thank Dr. Harold F. Deutsch (University of Wisconsin Medical School, Madison, WI) for editing this manuscript.
| |
FOOTNOTES |
|---|
* This work was supported by a postdoctoral fellowship from RIKEN (to T. T.) and by Grant-in-aid for Scientific Research on Priority Areas 10178104 from the Ministry of Education, Science, Sports, and Culture of Japan.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ Present address: Dept. of Cell Biology, Yale University School of Medicine, New Haven, CT 06520-8002.
** To whom correspondence should be addressed. Tel.: 81-6-6879-3420; Fax: 81-6-6879-3429; E-mail: proftani@biochem.med.osaka-u.ac.jp.
Published, JBC Papers in Press, July 19, 2000, DOI 10.1074/jbc.M004673200
| |
ABBREVIATIONS |
|---|
The abbreviations used are: GnTs, N-acetylglucosaminyltransferases; PA, 2-aminopyridine; MES, 2-(N-morpholino)ethanesulfonic acid; MOPS, 3-(N-morpholino)propanesulfonic acid; DTT, dithiothreitol.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Schachter, H. (1991) Glycobiology 1, 453-461 |
| 2. | Yamashita, K., Kamerling, J. P., and Kobata, A. (1982) J. Biol. Chem. 257, 12809-12814 |
| 3. | Parente, J. P., Wieruszeski, J.-M., Strecker, G., Montreuil, J., Fournet, B., van Halbeek, H., Dorland, L., and Vliegenthart, J. F. G. (1982) J. Biol. Chem. 257, 13173-13176 |
| 4. | Inoue, S., and Inoue, Y. (1997) in Glycoproteins II (Montreuil, J. , Vliegenthart, J. F. G. , and Schachter, H., eds) , pp. 143-161, Elsevier Science Publishing Co., Inc., New York |
| 5. | Oppenheimer, C. L., and Hill, R. L. (1981) J. Biol. Chem. 256, 799-804 |
| 6. | Nishikawa, Y., Pegg, W., Paulsen, H., and Schachter, H. (1988) J. Biol. Chem. 263, 8270-8281 |
| 7. | Kumar, R., Yang, J., Larsen, R. D., and Stanley, P. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 9948-9952 |
| 8. | Sarkar, M., Hull, E., Nishikawa, Y., Simpson, R. J., Moritz, R. L., Dunn, R., and Schachter, H. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 234-238 |
| 9. | Bendiak, B., and Schachter, H. (1987) J. Biol. Chem. 262, 5775-5783 |
| 10. | D'Agostaro, G. A. F., Zingoni, A., Moritz, R. L., Simpson, R. J., Schachter, H., and Bendiak, B. (1995) J. Biol. Chem. 270, 15211-15221 |
| 11. | Nishikawa, A., Ihara, Y., Hatakeyama, M., Kangawa, K., and Taniguchi, N. (1992) J. Biol. Chem. 267, 18199-18204 |
| 12. | Ihara, Y., Nishikawa, A., Tohma, T., Soejima, H., Niikawa, N., and Taniguchi, N. (1993) J. Biochem. (Tokyo) 113, 692-698 |
| 13. | Oguri, S., Minowa, M. T., Ihara, Y., Taniguchi, N., Ikenaga, H., and Takeuchi, M. (1997) J. Biol. Chem. 272, 22721-22727 |
| 14. | Minowa, M. T., Oguri, S., Yoshida, A., Hara, T., Iwamatsu, A., Ikenaga, H., and Takeuchi, M. (1998) J. Biol. Chem. 273, 11556-11562 |
| 15. | Yoshida, A., Minowa, M. T., Takamatsu, S., Hara, T., Oguri, S., Ikenaga, H., and Takeuchi, M. (1999) Glycobiology 9, 303-310 |
| 16. | Shoreibah, M. G., Hindsgaul, O., and Pierce, M. (1992) J. Biol. Chem. 267, 2920-2927 |
| 17. | Gu, J., Nishikawa, A., Tsuruoka, N., Ohno, M., Yamaguchi, N., Kangawa, K., and Taniguchi, N. (1993) J. Biochem. (Tokyo) 113, 614-619 |
| 18. | Shoreibah, M., Perng, G.-S., Adler, B., Weinstein, J., Basu, R., Cupples, R., Wen, D., Browne, J. K., Buckhaults, P., Fregien, N., and Pierce, M. (1993) J. Biol. Chem. 268, 15381-15385 |
| 19. | Saito, H., Nishikawa, A., Gu, J., Ihara, Y., Soejima, H., Wada, Y., Sekiya, C., Niikawa, N., and Taniguchi, N. (1994) Biochem. Biophys. Res. Commun. 198, 318-327 |
| 20. | Brockhausen, I., Hull, E., Hindsgaul, O., Schachter, H., Shah, R. N., Michnick, S. W., and Carver, J. P. (1989) J. Biol. Chem. 264, 11211-11221 |
| 21. | Taguchi, T., Ogawa, T., Kitajima, K., Inoue, S., Inoue, Y., Ihara, Y., Sakamoto, Y., Nagai, K., and Taniguchi, N. (1998) Anal. Biochem. 255, 155-157 |
| 22. | Nishikawa, A., Gu, J., Fujii, S., and Taniguchi, N. (1990) Biochim. Biophys. Acta 1035, 313-318 |
| 23. | Laemmli, U. K. (1970) Nature 227, 680-685 |
| 24. | Raju, T. S., and Stanley, P. (1998) J. Biol. Chem. 273, 14090-14098 |
| 25. | Taguchi, T., Kitajima, K., Inoue, S., Inoue, Y., Yang, J.-M., Schachter, H., and Brockhausen, I. (1997) Biochem. Biophys. Res. Commun. 230, 533-536 |
| 26. | Campion, B., Léger, D., Wieruszeski, J.-M., Montreuil, J., and Spik, G. (1989) Eur. J. Biochem. 184, 405-413 |
| 27. | Brockhausen, I., Möller, G., Yang, J.-M., Khan, S. H., Matta, K. L., Paulsen, H., Grey, A. A., Shah, R. N., and Schachter, H. (1992) Carbohydr. Res. 236, 281-299 |
This article has been cited by other articles:
![]() |
T. Watanabe, H. Ihara, E. Miyoshi, K. Honke, N. Taniguchi, and T. Taguchi A specific detection of GlcNAc{beta}1-6Man{alpha}1 branches in N-linked glycoproteins based on the specificity of N-acetylglucosaminyltransferase VI Glycobiology, May 1, 2006; 16(5): 431 - 439. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Korekane, T. Taguchi, Y. Sakamoto, K. Honke, N. Dohmae, H. Salminen, S. Toivonen, J. Helin, K. Takio, O. Renkonen, et al. Purification and cDNA cloning of UDP-GlcNAc:GlcNAc{beta}1-3Gal{beta}1-4Glc(NAc)-R [GlcNAc to Gal]{beta}1,6N-acetylglucosaminyltransferase from rat small intestine: a major carrier of dIGnT activity in rat small intestine Glycobiology, May 1, 2003; 13(5): 387 - 400. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sasai, Y. Ikeda, T. Fujii, T. Tsuda, and N. Taniguchi UDP-GlcNAc concentration is an important factor in the biosynthesis of {beta}1,6-branched oligosaccharides: regulation based on the kinetic properties of N-acetylglucosaminyltransferase V Glycobiology, February 1, 2002; 12(2): 119 - 127. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sakamoto, T. Taguchi, K. Honke, H. Korekane, H. Watanabe, Y. Tano, N. Dohmae, K. Takio, A. Horii, and N. Taniguchi Molecular Cloning and Expression of cDNA Encoding Chicken UDP-N-acetyl-D-glucosamine (GlcNAc): GlcNAcbeta 1-6(GlcNAcbeta 1-2)- Manalpha 1-R[GlcNAc to Man]beta 1,4N-acetylglucosaminyltransferase VI J. Biol. Chem., November 10, 2000; 275(46): 36029 - 36034. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |